Skip to content

Does Acetic acid Chromoendoscopy allow Improved Detection of Sessile Serrated Lesions? The ACID-SSL Trial

Acetic Acid Chromoendoscopy for Detection of Sessile Serrated Lesions During Screening Colonoscopy - A Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12625000884404
Acronym
ACID-SSL Trial
Enrollment
30
Registered
2025-08-13
Start date
2025-11-24
Completion date
2026-07-31
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

To determine whether acetic acid chromoendoscopy improves the detection rate of sessile serrated lesions during screening colonoscopy in average-risk patients. This outcome is measured by the proportion of colonoscopies that detect histologically confirmed sessile serrated lesion (SSL-DR).

Interventions

The intervention group underwent acetic acid chromoendoscopy using a 0.5% solution that was prepared fresh daily by diluting 3% or 5% acetic acid with normal saline. The concentration was determined based on preliminary dose-finding studies that balanced mucolysis effectiveness with minimal mucosal irritation. During withdrawal, approximately 30-50 mL of solution was applied to each colonic segment (cecum/ascending, transverse, descending/sigmoid) via a foot pump (Olympus). The timing is immedia

The intervention group underwent acetic acid chromoendoscopy using a 0.5% solution that was prepared fresh daily by diluting 3% or 5% acetic acid with normal saline. The concentration was determined based on preliminary dose-finding studies that balanced mucolysis effectiveness with minimal mucosal irritation. During withdrawal, approximately 30-50 mL of solution was applied to each colonic segment (cecum/ascending, transverse, descending/sigmoid) via a foot pump (Olympus). The timing is immediate (no delay). The procedure usually last 20minutes The Gastroenterologist using a foot pump administers the solution

Sponsors

Port Macquarie Gastroenterology
Lead SponsorOther

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Diagnosis
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Adults aged 18 years and older 2. Patients of Port Macquarie Gastroenterology 3. Scheduled for colonoscopy at Port Macquarie Private Hospital 4. Undergoing first-time or surveillance / screening colonoscopy 5. Average-risk individuals due for screening per national guidelines 6. Able to provide informed consent 7. Adequate bowel preparation anticipated 8. Complete colonoscopy to cecum expected

Exclusion criteria

1. Inflammatory bowel disease 2. Previous colorectal resection 3. Hereditary polyposis syndromes, Familial Adenomatous Polyposis (FAP) and Hereditary Nonpolyposis Colorectal Cancer (HNPCC). 4. Personal history of colorectal cancer 5. Pregnancy or lactation 6. Known allergy to acetic acid 7. ASA class IV-V

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026